Fresenius Medical Care (FMC) St. Aktie
43,76
EUR
-0,81
EUR
-1,82
%
Kursziele der Fresenius Medical Care (FMC) St.-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Fresenius Medical Care (FMC) St.-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Warburg Research | 36,00 EUR | -18,13% | 17.12.2024 | |
| Bernstein Research | 41,00 EUR | -6,75% | 12.12.2024 | |
| Jefferies & Company Inc. | - | - | 11.12.2024 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 47,00 EUR | +6,89% | 06.12.2024 | |
| JP Morgan Chase & Co. | 37,30 EUR | -15,17% | 03.12.2024 | |
| Goldman Sachs Group Inc. | 52,00 EUR | +18,26% | 02.12.2024 | |
| UBS AG | 39,00 EUR | -11,30% | 26.11.2024 | |
| Barclays Capital | 41,00 EUR | -6,75% | 21.11.2024 | |
| DZ BANK | - | - | 15.11.2024 | |
| Deutsche Bank AG | 34,00 EUR | -22,67% | 06.11.2024 | |
| Morgan Stanley | 33,00 EUR | -24,95% | 08.01.2024 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Baxter International Inc. | 0 | 0 | 0 | - | - |
| BB MEDTECH AG | 0 | 0 | 0 | - | - |
| Becton, Dickinson & Co. (BD) | 0 | 0 | 0 | - | - |
| Boston Scientific Corp. | 0 | 0 | 0 | - | - |
| Carl Zeiss Meditec AG | 1 | 5 | 3 | 64,94 EUR | +42,35% |
| DaVita HealthCare Partners Inc | 0 | 0 | 0 | - | - |
| Drägerwerk AG & Co. KGaA Vz. | 2 | 2 | 0 | 57,33 EUR | +26,84% |
| Fresenius Medical Care (FMC) St. | 2 | 5 | 4 | 40,03 EUR | -8,96% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 39,50 EUR | +17,88% |
| General Electric Co. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Medtronic PLC | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 98,86 CHF | +13,58% |
| Philips N.V. | 2 | 7 | 0 | 25,46 EUR | +5,60% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Siemens AG | 9 | 0 | 1 | 204,67 EUR | +7,82% |
| Smith & Nephew plc | 0 | 0 | 0 | - | - |
| St. Jude Medical Inc. | 0 | 0 | 0 | - | - |
| STRATEC SE | 2 | 3 | 0 | 40,00 EUR | +20,66% |
| Synthes Inc. | 0 | 0 | 0 | - | - |
| Zimmer Biomet | 0 | 0 | 0 | - | - |